This provider's $5.2M in total Medicare payments ranks in the 99th percentile of Centralized Flu providers nationally.
Medicare payments to this provider grew 1943% from 2016 to 2023.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 490% in 2021
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2016 | $46.08 | $45.16 | 1.02x | $0.92 | $72.0K | 2.9K | 2.9K |
| 2017 | $48.25 | $47.28 | 1.02x | $0.97 | $95.7K | 3.7K | 3.7K |
| 2018 | $47.72 | $46.72 | 1.02x | $1.00 | $155.6K | 6.2K | 6.2K |
| 2019 | $53.63 | $52.40 | 1.02x | $1.23 | $194.2K | 8.2K | 8.1K |
| 2020 | $60.84 | $59.20 | 1.03x | $1.64 | $311.2K | 10.7K | 10.7K |
| 2021 | $57.39 | $49.12 | 1.17x | $8.27 | $1.8M | 58.0K | 57.9K |
| 2022 | $66.74 | $53.77 | 1.24x | $12.97 | $1.0M | 26.2K | 26.1K |
| 2023 | $99.25 | $81.31 | 1.22x | $17.94 | $1.5M | 25.5K | 25.4K |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| G0008 | Administration of influenza virus vaccine | 36.4K | $791.3K | $21.76 | 2.06x |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | 10.0K | $696.4K | $69.57 | 1.02x |
| 0012A | Adm sarscov2 100mcg/0.5ml2nd | 12.6K | $455.1K | $36.09 | 1.23x |
| 91320 | Sarscv2 vac 30mcg trs-suc im | 3.5K | $454.8K | $128.48 | 1.14x |
| 0011A | Adm sarscov2 100mcg/0.5ml1st | 13.1K | $352.7K | $26.84 | 1.43x |
| 0013A | Fee covid-19 vac 2 booster | 7.7K | $304.8K | $39.74 | 1.28x |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | 11.0K | $229.0K | $20.90 | 1.02x |
| 0064A | Fee covid-19 vac 7 res | 5.8K | $226.7K | $39.19 | 1.30x |
| 90480 | Admn sarscov2 vacc 1 dose | 4.2K | $170.3K | $40.66 | 2.18x |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 595 | $166.9K | $280.55 | 1.02x |
| 90670 | Pneumococcal vaccine for injection into muscle | 725 | $153.2K | $211.27 | 1.01x |
| 90674 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | 4.9K | $145.1K | $29.59 | 1.00x |
| 90688 | Vaccine for influenza administered into muscle to individuals 3 years of age and older | 6.5K | $118.6K | $18.16 | 1.01x |
| 0134A | Fee covid-19 vac 14 res | 3.0K | $115.4K | $38.97 | 1.34x |
| 0124A | Fee covid-19 vac 13 res | 2.6K | $101.0K | $39.39 | 1.30x |
| 90756 | Vaccine for influenza for injection into muscle | 3.4K | $95.0K | $28.12 | 1.00x |
| 91322 | Sarscov2 vac 50 mcg/0.5ml im | 649 | $92.8K | $143.00 | 1.11x |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | 775 | $88.3K | $113.94 | 1.01x |
| 0003A | Fee covid-19 vac 1 booster | 1.9K | $78.3K | $41.21 | 1.24x |
| 0031A | Adm sarscov2 vac ad26 .5ml | 1.8K | $70.1K | $38.95 | 1.28x |
This provider submits charges 1.33 times higher than what Medicare actually pays.
A markup ratio of 1.33x means for every $100 Medicare pays, this provider initially charges $133. This is lower than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data